Pharma news, pharmaceutical news, Pharma Industry News, India Pharmaceutical Industry

Deccan Aviation gets DGCA permission to fly abroad
Idea, BSNL agree to interconnect RCom's GSM service
Flight cancelled due to workers strike
Cancel 11 flights to & from Kolkata on 20 Aug
To launch Mumbai services on Wednesday
Deccan Aviation gets permission to fly to UK
RBI relief bonds can be used as collateral for bk loan
July Producer Price Index at 27-year high; up 1.2%
U.S. Housing Starts down 11% in July, lowest in 17 years
Board okays buy back at price not exceeding Rs.350/share
Cannot say if interest rates have peaked: NW
RBI steps, inflation to determine interest rates : NW
BSE Power up 0.26% , Bankex up 0.10%
BSE Teck down 1.38% , Consumer Durables down 1.17%
CNX MidCap down 0.29% , BSE Small Cap down 0.34%
Sensex down 0.70% at 14,543.73
Nifty down 0.56% at 4,368.25
Expectations of U.K having 2 qtrs of -ve GDP growth
See further concerns emerging in U.S economy
Govt could be lender of last resort to Fannie and Freddie
EMs have seen $20bn fund outflows in last 10 weeks
Deccan Aviation granted traffic rights on India-UK sector
Revenues seen flowing in from Q4'09: Sources
Initial order size at $20-$25mn: Sources
Contracts to be signed within 3 months: Sources
Astrazeneca, Merck visited Dishman's facilities: Sources
Dishman to get orders from Merck & Astrazeneca: Srcs
India may import 3-3.5 MT of diesel this year : Oil Secy
To raise tractor prices this month : Escorts
Aluminium, Copper prices to remain weak in H2 FY'09

Updated: 19/08/08 | 06:24 PM IST

Pharma

Lupin enters into marketing alliance with Forest Lab

Pharma major Lupin Ltd on Tuesday said it has entered into a multi-year promotion and marketing management for AeroChamber Plus line of products with Forest Lab Inc.

Comments: Read (0 ) Post

Lupin enters into alliance with US firm

Pharmaceutical major Lupin Laboratories has entered into a promotion and marketing agreement with US-based Forest Laboratories for its Aerochamber line of products, it announced on Tuesday.

Comments: Read (0 ) Post

Indian generic drugmakers see big market in Japan

Indian drug makers are queuing up in Japan trying to get a first mover's advantage in a market, which is set to open its doors especially for generic pharmaceutical companies as they plan to flood the land of the rising sun with cheaper versions of blockbuster drugs.

Comments: Read (0 ) Post

India seeks US help to resolve Ranbaxy-FDA issue

India has sought the intervention of the US government in the case of Ranbaxy Laboratories, which is fighting the charges of fraudulent misconduct, levelled by the Department of Justice (DoJ), in district court of Maryland.

Comments: Read (0 ) Post

Zydus and WHO to develop next-generation biological to fight rabies

Zydus Cadila has entered into an agreement with WHO to explore a possible collaboration in the development of a cocktail for the treatment of rabies.

Comments: Read (0 ) Post

Govt approves Daiichi's takeover of Ranbaxy

Government on Wednesday announced the approval of Japan-based Daiichi Sankyo's proposed acquisition of shares in domestic pharma major Ranbaxy.

Comments: Read (0 ) Post

Dr Reddy's promoter group firm hikes stake to 22.82%

Domestic pharma major Dr Reddy's Labs has said that a promoter group firm Dr Reddy's Laboratories Holdings Pvt Ltd has increased its stake in the company to 22.82 per cent through open market purchase.

Comments: Read (0 ) Post

Daiichi's open offer for 20% in Ranbaxy to open on August 16

Ranbaxy Laboratories on Tuesday said that the open offer by the Japanese drug maker Daiichi Sankyo for acquiring an additional 20 per cent stake in it will commence on August 16.

Comments: Read (0 ) Post

Daiichi gets SEBI, FIPB nod for Ranbaxy stake

Japanese drug maker Daiichi Sankyo on Monday received approvals from the market regulator SEBI and Foreign Investment Promotion Board for the acquisition of 34.8 per cent stake in the Indian drug major Ranbaxy.

Comments: Read (0 ) Post

Orchid Chem receives EU approval for bacterial injection

Orchid Chemicals and Pharmaceuticals on Monday said it has received European Union regulatory approval for marketing Piperacillin and Tazobactam injection, used in the treatment of bacterial infection.

Comments: Read (0 ) Post

Pages:

Special

Wholesale prices in the US rising at fastest pace since 1981

The US Labor Department said its Producer Price Index rose by 1.2 per cent in July, pushed higher by rising costs for energy and motor vehicles. Food prices rose by 0.3 per cent.

More : NDTV Specials | New law in US to rein in market manipulators

Market Watch

Graphs

Stocks